Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125245392 | 12524539 | 2 | F | 20020101 | 20160701 | 20160704 | 20160712 | EXP | PHHY2016GB087969 | SANDOZ | 23.00 | YR | M | Y | 0.00000 | 20160713 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125245392 | 12524539 | 1 | PS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 13.5 MG, QD | U | 75566 | 13.5 | MG | QD | ||||||
| 125245392 | 12524539 | 2 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 30 MG, QD | U | 75566 | 30 | MG | QD | ||||||
| 125245392 | 12524539 | 3 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 16.5 MG, QD | U | 75566 | 16.5 | MG | QD | ||||||
| 125245392 | 12524539 | 4 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125245392 | 12524539 | 5 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 4.5 MG, QD | U | 0 | 4.5 | MG | QD | ||||||
| 125245392 | 12524539 | 6 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125245392 | 12524539 | 7 | SS | SEROXAT | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 4.5 MG, QD | 7213.68799 | MG | U | 0 | 4.5 | MG | QD | ||||
| 125245392 | 12524539 | 8 | C | BUSPAR | BUSPIRONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125245392 | 12524539 | 9 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | U | 0 | ||||||||||
| 125245392 | 12524539 | 10 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125245392 | 12524539 | 1 | Social anxiety disorder |
| 125245392 | 12524539 | 4 | Depression |
| 125245392 | 12524539 | 5 | Product used for unknown indication |
| 125245392 | 12524539 | 6 | Anxiety |
| 125245392 | 12524539 | 7 | Product used for unknown indication |
| 125245392 | 12524539 | 8 | Product used for unknown indication |
| 125245392 | 12524539 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125245392 | 12524539 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125245392 | 12524539 | Abdominal pain | |
| 125245392 | 12524539 | Adverse drug reaction | |
| 125245392 | 12524539 | Agitation | |
| 125245392 | 12524539 | Anxiety | |
| 125245392 | 12524539 | Confusional state | |
| 125245392 | 12524539 | Decreased appetite | |
| 125245392 | 12524539 | Depressed mood | |
| 125245392 | 12524539 | Diarrhoea | |
| 125245392 | 12524539 | Disturbance in attention | |
| 125245392 | 12524539 | Dizziness | |
| 125245392 | 12524539 | Drug dependence | |
| 125245392 | 12524539 | Erectile dysfunction | |
| 125245392 | 12524539 | Fatigue | |
| 125245392 | 12524539 | Fear | |
| 125245392 | 12524539 | Feeling abnormal | |
| 125245392 | 12524539 | Feeling of despair | |
| 125245392 | 12524539 | Gastroenteritis | |
| 125245392 | 12524539 | Hyperhidrosis | |
| 125245392 | 12524539 | Influenza like illness | |
| 125245392 | 12524539 | Insomnia | |
| 125245392 | 12524539 | Lethargy | |
| 125245392 | 12524539 | Malaise | |
| 125245392 | 12524539 | Memory impairment | |
| 125245392 | 12524539 | Micturition urgency | |
| 125245392 | 12524539 | Mood altered | |
| 125245392 | 12524539 | Myalgia | |
| 125245392 | 12524539 | Nausea | |
| 125245392 | 12524539 | Nightmare | |
| 125245392 | 12524539 | Panic disorder | |
| 125245392 | 12524539 | Paraesthesia | |
| 125245392 | 12524539 | Pollakiuria | |
| 125245392 | 12524539 | Rebound effect | |
| 125245392 | 12524539 | Self esteem decreased | |
| 125245392 | 12524539 | Skin burning sensation | |
| 125245392 | 12524539 | Sleep disorder | |
| 125245392 | 12524539 | Suicidal ideation | |
| 125245392 | 12524539 | Tachyphrenia | |
| 125245392 | 12524539 | Tremor | |
| 125245392 | 12524539 | Vomiting | |
| 125245392 | 12524539 | Weight decreased | |
| 125245392 | 12524539 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125245392 | 12524539 | 4 | 19970812 | 0 | ||
| 125245392 | 12524539 | 5 | 19970812 | 0 | ||
| 125245392 | 12524539 | 7 | 19970812 | 0 | ||
| 125245392 | 12524539 | 9 | 20051004 | 0 | ||
| 125245392 | 12524539 | 10 | 20051004 | 0 |